Barton Blair M, Riley Charles A, Fitzpatrick John C, Hasney Christian P, Moore Brian A, McCoul Edward D
Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine, New Orleans, Louisiana.
University of Mississippi School of Medicine, Jackson, Mississippi.
Laryngoscope. 2018 Feb;128(2):412-421. doi: 10.1002/lary.26703. Epub 2017 Jun 5.
OBJECTIVE: Postoperative use of anticoagulation after free tissue transfer in head and neck ablative procedures is common practice, but a clear protocol has not been well established. The outcome measures including total flap failure, thrombosis, and hematoma formation for different anticoagulation regimens in free tissue transfer in the head and neck were reviewed. DATA SOURCES: PubMed, Ovid, and Cochrane databases were examined for patients who underwent free tissue transfer following head and neck ablative procedures. REVIEW METHODS: Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were utilized to identify English-language studies reporting anticoagulation regimens following free tissue transfer in head and neck ablative procedures. Outcomes included total flap failure, thrombosis, and hematoma formation. Two independent reviewers assessed the quality of the articles by using the Methodological Index for Non-Randomized Studies. RESULTS: A total of 368 articles were identified. An additional 36 articles were identified through screening of reference lists. Twenty-one of these studies met final inclusion criteria for qualitative analysis. Outcome data on total flap failure, thrombosis, and hematoma formation were extracted and analyzed for comparison against all anticoagulation regimens. Total flap failure, thrombosis, and hematoma formation rates were 4.4%, 4.5%, and 2.2%, respectively. Individual study rates ranged from 0.0% to 10.7%, 0.0% to 10.4%, and 0.6% to 7.2%, respectively. CONCLUSIONS: There is not adequate evidence to develop a standardized anticoagulation protocol for head and neck free flap procedures. Comparable flap complications were reported between all the employed anticoagulation methods studied, though significant variability in study design among articles existed. Prospective, randomized studies are warranted to determine the optimal postoperative anticoagulation regimen following free tissue transfer of the head and neck. Laryngoscope, 128:412-421, 2018.
目的:在头颈部切除手术中,游离组织移植术后使用抗凝剂是常见做法,但尚未建立明确的方案。回顾了头颈部游离组织移植中不同抗凝方案的结局指标,包括皮瓣完全坏死、血栓形成和血肿形成情况。 数据来源:检索了PubMed、Ovid和Cochrane数据库,纳入头颈部切除手术后接受游离组织移植的患者。 综述方法:采用系统评价和Meta分析的首选报告项目指南,以识别报告头颈部切除手术游离组织移植后抗凝方案的英文研究。结局包括皮瓣完全坏死、血栓形成和血肿形成。两名独立审稿人使用非随机研究方法学指数评估文章质量。 结果:共识别出368篇文章。通过筛选参考文献列表又识别出36篇文章。其中21项研究符合定性分析的最终纳入标准。提取并分析了皮瓣完全坏死、血栓形成和血肿形成的结局数据,以比较所有抗凝方案。皮瓣完全坏死、血栓形成和血肿形成率分别为4.4%、4.5%和2.2%。各研究的发生率分别为0.0%至10.7%、0.0%至10.4%和0.6%至7.2%。 结论:没有足够的证据来制定头颈部游离皮瓣手术的标准化抗凝方案。在所研究的所有使用的抗凝方法之间,报告的皮瓣并发症相似,尽管各文章的研究设计存在显著差异。有必要进行前瞻性随机研究,以确定头颈部游离组织移植术后的最佳抗凝方案。《喉镜》,2018年,第128卷,第412 - 421页。
Health Technol Assess. 2001
Ear Nose Throat J. 2018-7
Cochrane Database Syst Rev. 2018-7-13
Cochrane Database Syst Rev. 2018-4-24
Cochrane Database Syst Rev. 2004-10-18
Cochrane Database Syst Rev. 2006-4-19
Oral Maxillofac Surg. 2025-2-12
Aesthetic Plast Surg. 2025-6
J Maxillofac Oral Surg. 2023-3
Indian J Otolaryngol Head Neck Surg. 2022-10
J Nanobiotechnology. 2022-10-14